Doxofylline Ip - White Powder, 25kg Drums | Bronchodilator, Asthma Relief, Copd Treatment, Smooth Muscle Relaxant

Get Latest Price

Minimum Order Quantity :

100 Kilograms

In Stock

Product Specifications

CAS Number	12171-69-6
Molecular Formula	C13H12N4O3
Molecular Weight	272.26 g/mol
Purity	99.5% min
Appearance	White powder
Packaging	25kg drums
Usage	Pharmaceutical ingredient for treating asthma and COPD. Used in the manufacture of respiratory medications.
Features	Bronchodilator, Asthma relief, COPD treatment, Smooth muscle relaxant
Supply Ability	100 Per Week
Delivery Time	1 Week

Company Details

Business Type

Exporter, Importer, Manufacturer, Supplier

Employee Count

120

Establishment

1988

Working Days

Monday To Saturday

GST NO

24AAACH4736M1ZH

Certification

Env & Safety ISO 14001:2015

More Products From This Seller

Seller Details

Hema Pharmaceuticals Pvt. Ltd.

GST - 24AAACH4736M1ZH

Rating

TrustedSeller

Ankleshwar, Gujarat

Name

Mr Jignesh Chodvadiya

Members since

15 Years

Address

Plot No.: 6201/A &B, Opp. EWAC Alloys, GIDC Estate, Ankleshwar, Gujarat, 393002, India

Report incorrect details

Compare With Similar Products

Product Name

Doxofylline IP/BP/USP

Doxofylline

Buyer Feedback

Minimum Order Quantity

100 Kilograms/Kilograms

5 Kilograms/Kilograms

10 Kilograms/Kilograms

Supply Ability

100 Per Week

50 Per Week

10 Per Day

Delivery Time

1 Week

1 Days

7 Days

Price Or Price Range

1 INR (Approx.)

1850.00 - 2200.00 INR (Approx.)

Storage

Room Temperature

Molecular Weight

266.257 Grams (g)

266.25 Grams (g)

Color

WHITE

Molecular Formula

C11H14N4O4

HS Code

29420090

Taste

Odorless

Other

Smell

Resinous

No Smell

CAS No

69975-86-6

Grade

Medicine Grade

Usage

Doxofylline drug used in the treatment of asthma

This medicine highly used for asthma and other difficult disease. It is use to treatment of symptoms related with chronic asthma and other difficult disease of the lungs. It is essentially used as a maintenance therapy. This medicine also used for COPD and bronchospasm. It has shown similar efficacy to theophylline in animal and human studies but with importantly fever side effects. The US FDA granted an orphan drug designation to Doxofylline for the treatment of bronchiectasis. In difference with other xanthine derivatives. Doxofylline does not importantly bind to adenosine alpha-1 or alpha-2 receptors and lacks stimulating effects. It does not affects calcium influx and does not affect calcium influx and also not antagonize the actions of calcium channel blockers which could explain reduced cardiac side reactions as related the drug.

Purity(%)

98% TO 102%

Physical Form

Powder

FOB Port

NHAVA SHEVA

NhavaSheva By Sea and Sahar Airport By Air

Payment Terms

Cash on Delivery (COD), Cash Advance (CA), Cheque, Letter of Credit (L/C), Western Union, Others, Letter of Credit at Sight (Sight L/C), Cash Against Delivery (CAD), Telegraphic Transfer (T/T), Delivery Point (DP), Days after Acceptance (DA), Cash in Advance (CID)

Cash on Delivery (COD), Letter of Credit (L/C), Telegraphic Transfer (T/T), Paypal, Western Union, Letter of Credit at Sight (Sight L/C), Cash Against Delivery (CAD), Others, Delivery Point (DP), Days after Acceptance (DA), Cash in Advance (CID), Cheque, Cash Advance (CA)

Sample Policy

Free samples are available

Packaging Details

HDPE Drum with two LDPE inner liners

HDPE drum with inner LPDE liners

Main Export Market(s)

Australia, South America, Eastern Europe, Western Europe, Middle East, Africa, Central America, Asia, North America

Western Europe, Australia, North America, South America, Eastern Europe, Middle East, Central America, Asia, Africa

Main Domestic Market

Sikkim, Tripura, Himachal Pradesh, Manipur, Andaman and Nicobar Islands, Uttarakhand, Dadra and Nagar Haveli, Lakshadweep, Daman and Diu, South India, East India, West India, Assam, Arunachal Pradesh, Bihar, Chandigarh, Goa, Haryana, Jammu and Kashmir, Jharkhand, Kerala, Maharashtra, Mizoram, Meghalaya, Nagaland, Punjab, Pondicherry, Rajasthan, Tamil Nadu, Telangana, Uttar Pradesh, West Bengal, Delhi, Gujarat, Madhya Pradesh, Karnataka, North India, Andhra Pradesh, Central India, Odisha, Chhattisgarh, All India

Andaman and Nicobar Islands, Uttarakhand, Daman and Diu, Dadra and Nagar Haveli, Lakshadweep, South India, East India, Assam, Arunachal Pradesh, Bihar, Chandigarh, Goa, Haryana, Himachal Pradesh, Jammu and Kashmir, Jharkhand, Karnataka, Madhya Pradesh, Maharashtra, Mizoram, Meghalaya, Manipur, Punjab, Pondicherry, Rajasthan, Sikkim, Tamil Nadu, Telangana, Tripura, West Bengal, Nagaland, Kerala, Delhi, Gujarat, North India, Andhra Pradesh, Central India, Odisha, West India, Uttar Pradesh, Chhattisgarh, All India

Sold By

Hema Pharmaceuticals Pvt. Ltd.
Ankleshwar, Gujarat

Sakhiya Pharma Chem
Surat, Gujarat

Dayaram Pharma Chem
Ankleshwar, Gujarat